Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quintiles, a US-based biopharma services company which offers clinical, commercial, consulting and capital solutions, has inaugurated its new Phase I research facility in Hyderabad, India, at Apollo Health City.
Subscribe to our email newsletter
According to Quintiles, the new facility has been constructed jointly with Apollo Hospitals Group and offers biopharma customers additional options to complete integrated Phase I programs across multiple geographies at this pivotal stage in medical research.
The new facility houses 86 beds, out of which 32 beds are equipped with diagnostic cardiology equipment for TQT studies.
The new Hyderabad facility is expected to assess compounds developed both in India and in other countries.
Data capture will be linked electronically to Quintiles other Phase I units in the UK, the US and Sweden.